The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

What this study is about

The Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based implementation of the Unity MR-Linac technology and further technical development of the MR-Linac system with the ultimate purpose to improve patients' survival, local, and regional tumor control and quality of life.

Who can join (things the study team will check)

✅ You may be able to join if…

• Patient is to undergo or has completed imaging or treatment procedures on an MR-Linac;
• Patient provides written, informed consent;
• Patient is 18 years old or older.

🚫 You may not be able to join if…

• MRI exclusion criteria, including
• MRI contraindications as per usual clinical care, such as (possible) pregnancy; claustrophobia and metal or electronic implants not compatible with MRI.

Where this trial is running

• Allegheny Health Network, Pittsburgh, Pennsylvania, United States
• Md Anderson Cancer Center, Houston, Texas, United States
• Medical College of Wisconsin, Milwaukee, Wisconsin, United States
• Austin Health - Olivia Newton-John Cancer Wellness and Research Centre, Melbourne, Australia
• Insitut Jules Bordet, Brussels, Belgium
• Sunnybrook Health Sciences Centre/Odette Cancer Centre, Toronto, Ontario, Canada
• University Health Network - Princess Margaret Cancer Center, Toronto, Canada
• Odense Universitetshospital, Odense, Funen, Denmark
• Universitätsklinikum Tübingen, Tübingen, Germany
• Università degli Studi di Brescia, Brescia, Italy
• IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, Italy
• Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands

+ 6 more sites.

Who to contact

Tessa Leer · T +31 (0)88 75 63707 · T.Leer@umcutrecht.nl

It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT04075305.